The results showed that FOXF2 mRNA levels significantly decreased with increased tumor size (Z/χ2 = 7.302, P = 0.026; χ2 = 9.744, P = 0.008), increased numbers of metastatic lymph nodes (Z/χ2 = 8.288, P = 0.040; χ2 = 7.584, P = 0.055), and elevated clinical stage (Z/χ2 = 5.867, P = 0.053; χ2 = 8.832, P = 0.012). This evidence concerns the gene FOXF2 and neoplasm.